Yat Sun Or, Chief Scientific Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 10,000 shares at $40.36 ($393K) on 2014-03-24, disclosed to the SEC on 2014-03-25.
Scheduled sale ($393k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.42 | 4,363 | $168K | 42.6% |
| 2 | $39.66 | 2,521 | $100K | 25.4% |
| 3 | $40.36 | 3,116 | $126K | 32.0% |
| Total | $39.34 avg | 10,000 | $393K | 100% |
| Filing → |
| ENTA | SELL | 2023-12-06 | $23K | — | Filing → |
| ENTA | SELL | 2023-03-17 | $1.2M | — | Filing → |
| ENTA | SELL | 2019-03-04 | $2.1M | — | Filing → |